The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SWOG S1826, a randomized study of nivolumab(N)-AVD versus brentuximab vedotin(BV)-AVD in advanced stage (AS) classic Hodgkin lymphoma (HL).
 
Alex Francisco Herrera
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Adicet Bio; AstraZeneca/MedImmune; Bristol-Myers Squibb; Caribou Biosciences; Genentech/Roche; Genmab; Karyopharm Therapeutics; Merck; Pfizer; Regeneron; Seagen; Takeda; Tubulis GmbH
Research Funding - ADC Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Kite, a Gilead company (Inst); Merck (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Michael Leo LeBlanc
Consulting or Advisory Role - Agios
 
Sharon M. Castellino
Consulting or Advisory Role - Seagen
Research Funding - Seagen (Inst)
(OPTIONAL) Uncompensated Relationships - Seagen
 
Hongli Li
No Relationships to Disclose
 
Sarah C. Rutherford
Consulting or Advisory Role - ADC Therapeutics; Genmab; Karyopharm Therapeutics; Kite, a Gilead company; Seagan
Research Funding - Genentech (Inst); Karyopharm Therapeutics (Inst)
 
Andrew M. Evens
Honoraria - Abbvie/Pharmacyclics; Cota Healthcare; Curio Science; Daiichi Sankyo/Astra Zeneca; Epizyme; HMP; HUTCHMED; Incyte; Miltenyi Biotec; MorphoSys; MorphoSys; Novartis; OncLive Clinical Congress Consultants; Patient Power; PER; Pharmacyclics; Research to Practice; Seagen; Takeda; Targeted Oncology; WebMD
Consulting or Advisory Role - Abbvie; Cota Healthcare; Epizyme; Incyte; Miltenyi Biotec; MorphoSys; MorphoSys; Novartis; Pharmacyclics; Seagen
Speakers' Bureau - Curio Science; Research to Practice
Travel, Accommodations, Expenses - Curio Science; Novartis; Seagen
 
Kelly Davison
Consulting or Advisory Role - Abbvie; BeiGene; Bristol-Myers Squibb/Celgene; Incyte; Janssen
Research Funding - Kite/Gilead (Inst); Merck (Inst); Novartis (Inst); Roche (Inst); Seagen
 
Angela Punnett
No Relationships to Disclose
 
David C. Hodgson
No Relationships to Disclose
 
Susan K. Parsons
Consulting or Advisory Role - Seagen
 
Sairah Ahmed
Honoraria - ADC Therapeutics
Consulting or Advisory Role - Myeloid Therapeutics; Sanofi; Tessa Therapeutics
Research Funding - Chimagen Biosciences (Inst); Merck (Inst); Seagen (Inst); Tessa Therapeutics (Inst); Xencor (Inst)
 
Carla Casulo
Research Funding - Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
Nancy L. Bartlett
Consulting or Advisory Role - ADC Therapeutics; Foresight Diagnostics; Kite, a Gilead company; Roche/Genentech; Seagen
Research Funding - ADC Therapeutics (Inst); Autolus (Inst); Bristol-Myers Squibb/Celgene; Forty Seven (Inst); Janssen (Inst); Kite, a Gilead company; Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Joo Y Song
No Relationships to Disclose
 
Richard F. Little
No Relationships to Disclose
 
Brad S. Kahl
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; BeiGene; Bristol-Myers Squibb; Genentech; Incyte; Janssen; Kite/Gilead; MEI Pharma; Roche; Seattle Genetics/Astellas; TG Therapeutics
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Genentech (Inst)
 
John Paul Leonard
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Calithera Biosciences; Celgene; Constellation Pharmaceuticals; Eisai; Epizyme; Genentech/Roche; Genmab; Gilead Sciences; Grail; Incyte; Janssen Oncology; Karyopharm Therapeutics; Lilly; MEI Pharma; Merck; Morphosys; MustangBio; Novartis; Pfizer; Seagen; Second Genome; Sutro Biopharma
Research Funding - Alliance for Clinical Trials in Oncology (Inst); Celgene (Inst); Epizyme (Inst); Genentech (Inst); Janssen Oncology (Inst); National Cancer Institute (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - BeiGene
 
Kara M Kelly
Research Funding - Merck (Inst)
(OPTIONAL) Uncompensated Relationships - Seagen
 
Sonali M. Smith
Employment - Caris Life Sciences (I)
Consulting or Advisory Role - Bristol Myers Squibb; Gilead Sciences; MorphoSys; Ono Pharmaceutical
Research Funding - Acerta Pharma (Inst); Bristol Myers Squibb (Inst); Celgene (Inst); Curis (Inst); Epizyme (Inst); Forty Seven (Inst); Genentech (Inst); Merck (Inst); Novartis (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); TGTX (Inst)
 
Jonathan W. Friedberg
Research Funding - Enterome (Inst)
Patents, Royalties, Other Intellectual Property - Patient on bone marrow microenvironment signals (I)